Bovine semen to the Republic of Korea

2 July 2010

bovsemec.kor

Ref:  AE-KR-05L

1.  Statutory authority

Pursuant to section 60 of the Animal Products Act 1999:

(i)  I notify the following overseas market access requirements, entitled bovine semen to the Republic of Korea.

This notice takes effect from date of signing.

Dated at Wellington this 11th day of August 2010.

 

Signed: Matthew Stone BVSc MACVSc MVS (Epidemiology)
Group Manager
Animal Imports and Exports
Border Standards Directorate
MAF Biosecurity New Zealand
(pursuant to delegated authority)

 

2.  The Republic of Korea requirements

Bovine semen exported from New Zealand to the Republic of Korea must comply with the import requirements of the Republic of Korea listed in this notice as follows:

2.1  An Import Permit is required for the exportation of bovine semen to the Republic of Korea.

2.2  An Official Veterinarian authorised by New Zealand Ministry of Agriculture and Forestry must certify, after due enquiry the following:

2.2.1  New Zealand is free of bluetongue, bovine spongiform encephalopathy (BSE), brucellosis (Brucella abortus & B. melitensis), contagious bovine pleuropneumonia, foot-and-mouth disease, rinderpest, and vesicular stomatitis. Vaccination against these diseases is prohibited.

2.2.2  The feeding of ruminant protein to ruminants is prohibited in New Zealand.

2.2.3  New Zealand prohibits the importation of ruminants from BSE infected countries.

2.2.4  The semen collection centre(s):

2.2.4.1  is approved by the New Zealand Ministry of Agriculture and Forestry

2.2.4.2  is under the direct supervision and sanitary control of a centre veterinarian who is approved by the New Zealand Ministry of Agriculture and Forestry

2.2.4.3  is routinely inspected by an Official Veterinarian of the New Zealand Ministry of Agriculture and Forestry.

2.2.5  No confirmed cases of bluetongue, bovine spongiform encephalopathy (BSE), bovine tuberculosis (Mycobacterium bovis), brucellosis (Brucella abortus), bovine viral diarrhoea/mucosal disease (BVD/MD), contagious bovine pleuropneumonia, enzootic bovine leukosis (EBL), foot-and-mouth disease, infectious bovine rhinotracheitis, Johne’s disease (Mycobacterium avium subsp. paratuberculosis), leptospirosis, rinderpest, trichomonosis (Trichomonas foetus), vesicular stomatitis and vibriosis (Campylobacter fetus subsp. venerealis) have occurred on the semen collection centre during the 12 months prior to the first collection and until at least 30 days after the last collection of semen for export to Korea.

2.2.6  The donors were born and raised in New Zealand, or have been continuously resident in New Zealand for at least six (6) months prior to entry into the semen collection centre.

2.2.7  The donor bulls originated from a property that has been officially free of bovine tuberculosis for at least two (2) years prior to entry of the bulls into the semen collection centre. 

2.2.8  The donor bulls were tested/treated for the following diseases while resident at the semen centre and within six (6) months prior to semen collection, with negative results (for testing) in each case:

2.2.8.1  Bovine brucellosis - B. abortus (SAT, negative at 1:50 or 50 IU/ml). Date sample taken

2.2.8.2  Bovine tuberculosis - Mycobacterium bovis (intradermal tuberculin test). Date test read

2.2.8.3  BVD-MD virus infection on semen (virus isolation test or antigen ELISA)*. Date sample taken

(*To be deleted as appropriate)

2.2.8.4  Campylobacter fetus subsp. venerealis (Vibriosis) using culture of a preputial sample. Date of test

2.2.8.5  Enzootic bovine leukosis (AGID or ELISA)*. Date of test

(*To be deleted as appropriate)

2.2.8.6  Infectious bovine rhinotracheitis:

either  2.2.8.6.1 a virus neutralisation test or an ELISA on whole blood*

or  2.2.8.6.2 virus culture on semen*. Date of test

(*To be deleted as appropriate)

2.2.8.7  Johne’s disease - Mycobacterium avium subsp. paratuberculosis (CFT or ELISA)*. Date sample taken

(*To be deleted as appropriate)

2.2.8.8  Leptospirosis (MAT, negative is less than 50% agglutination at 1:100). Date sample taken

2.2.8.9  Trichomonas foetus (trichomonosis), using microscopic examination and culture of a preputial sample. Date of test.

2.2.9  All serological testing of bulls was carried out at a laboratory that is approved by the New Zealand Ministry of Agriculture and Forestry to undertake testing for export purposes.

2.2.10  On entry into the semen collection centre the bulls were examined by the semen collection centre veterinarian, and were found to be clinically healthy and free from bluetongue, bovine tuberculosis (Mycobacterium bovis), brucellosis (Brucella abortus), bovine viral diarrhoea/mucosal disease (BVD/MD), enzootic bovine leukosis (EBL), Johne’s disease (Mycobacterium avium subsp. paratuberculosis), leptospirosis, trichomonosis (Trichomonas foetus), vesicular stomatitis and vibriosis (Campylobacter fetus subsp. venerealis).

2.2.11  On the day of collection the donor bulls showed no clinical evidence of cases of bluetongue, bovine tuberculosis (Mycobacterium bovis), brucellosis (Brucella abortus), bovine viral diarrhoea/mucosal disease (BVD/MD), enzootic bovine leukosis (EBL), Johne’s disease (Mycobacterium avium subsp. paratuberculosis), leptospirosis, trichomonosis (Trichomonas foetus), vesicular stomatitis and vibriosis (Campylobacter fetus subsp. venerealis).

2.2.12  The semen was collected, processed and stored in accordance with procedures that prevent contamination or dissemination of contagious livestock diseases.

2.2.13  All additives, diluents or extenders do not contain any animal-derived substance, apart from UHT milk or egg yolk produced in New Zealand, or only animal-derived substance known to be free of the diseases listed in sections 1 and 4 of the export certificate.

2.2.14  Following collection, the semen was processed and placed in individual ampoules or straws indelibly marked either with the name of the donor animal, its registration number and the date of collection, or a code from which this information may be determined. If a code or cipher is used for this information, the method of deciphering must accompany the consignment.

2.2.15  The semen was only processed and stored with semen of equivalent centre health status.

2.2.16  The ingredients of the diluent. Name of ingredients.

2.2.17  The approximate semen concentration.

2.2.18  The antibiotics added to the diluent. Name of antibiotics and concentration.

2.2.19  The container used for transportation of the semen contained only new liquid nitrogen, and was new or disinfected prior to loading*.

(*To be deleted as appropriate)

2.2.20  Prior to export the transportation container was sealed by an Official Veterinarian using a seal bearing the marks. Serial number of the container.

 

3.  Definitions

For the purposes of this document:

Any term or expression that is defined in the Animal Products Act 1999 and used, but not defined in this document, has the same meaning as in this Act.

Explanatory note

These overseas market access requirements are based on the export certificate for bovine semen to the Republic of Korea, dated 2 July 2010.

 

Additional Information on OMAR Notification: BOVSEMEC.KOR 02.07.10

1.  This is a new OMAR based on the export certificate which is based on the “Revised MAF Notification No. 90-52 December 21, 1990” received on 11 April 2008. Received notification from MFAT of the approval of the export certificate on 16 July 2010.

2.  An Import Permit is required.

3.  With regards to Clause 2.2.8.1 (bovine brucellosis), a negative result at 1:50 dilution, using the American method, corresponds to less than 30 IU/ml.

4.  With regards to Clause 2.2.8.8 (leptospirosis), the animals should be tested for the serovars Leptospira Hardjobovisand L. Pomona.

5.  With regards to Clause  2.2.15 (semen processing and storage), ‘centre health status’ refers to the tested health status of the donor bulls as per the revised Official Assurance Programme of 1 September 2008, which involves the annual testing for bovine tuberculosis, bovine viral diarrhoea/mucosal disease, bovine genital campylobacteriosis, trichomoniosis and enzootic bovine leukosis.     

 

Section 61.A of the Animal Products Amendments Act 2005 states that 'The Crown is not liable, and nor is the Director-General or any employee of the Ministry liable, for any loss arising through the refusal or failure of the relevant authority of an overseas market to admit export animal material or animal product to that market.'